EUVIMEDEUVIMED entdecken
Crossref

Recipient Periodic Fasting Promotes Osteogenesis of Implanted Mesenchymal Stromal Cell Aggregates and Safeguards Diabetic Mandibular Bone Regeneration

Zi-Qi Zhang, Yuan Yuan, Xiao-Hui Zhang, Jia-Ning Liu, Yuan Cao, Lu Liu, Lu-Fan Yang, Yi-Han Xiao, Shan-Shan Huang, Bing-Dong Sui, Jian-Fei Liang, Ji Chen und 6 weitere

Stem Cell Reviews and Reports · 2025

DOI: 10.1007/s12015-025-10975-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cell Reviews and Reports, 2025. Verfasst von Zi-Qi Zhang und 17 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration & National Clinical Research Center for Oral Diseases & Shaanxi Internat…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Bone Regeneration, Osteogenesis, Mandible. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Project of State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, the Young Science and Technology Rising Star Project of Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus (T2DM) disrupts bone metabolism, exacerbating craniomaxillofacial bone loss and impairing the efficacy of regenerative therapies. While mesenchymal stromal cell (MSC)-based approaches, including MSC-derived cell aggregates (CAs), have shown promise in tissue regeneration across multiple organs, their regenerative capacity is significantly compromised in recipient diseased microenvironments. Here, using a high-fat diet (HFD)-induced T2DM murine model, this study reveals that CA implantation fails to boost osteogenesis or restore mandibular bone defects in diabetic mice due to systemic metabolic dysregulation. To address this limitation, we propose a combinatorial strategy integrating CAs with recipient periodic fasting, a metabolic intervention shown to alleviate lipidemia thus creating a beneficial condition for regeneration. Remarkably, the combined therapy enhances osteogenesis and safeguards mandibular bone regeneration in diabetic mice, evidenced by increased trabecular bone volume, reduced trabecular spacing, and elevated RUNX2 expression in defect areas. This combinatorial approach overcomes the limitations of standalone MSC therapies, highlighting the importance of addressing both local tissue repair and systemic metabolic dysregulation in diabetic bone regeneration. The findings propose a novel strategy integrating cellular engineering with metabolic interventions to optimize tissue regeneration in T2DM-related complications, offering translational potential for improving dental rehabilitation in diabetic patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsBone RegenerationOsteogenesisMandibleMesenchymal Stem Cell TransplantationFastingDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2AnimalsMiceMaleMice, Inbred C57BLDiet, High-FatCell Aggregation

Stichwörter der Autor:innen

Cell aggregatesFastingMandibular bone defectMesenchymal stromal cellsTissue regenerationType 2 diabetes mellitus

Autor:innen und Institutionen

  • State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration & National Clinical Research Center for Oral Diseases & Shaanxi International Joint Research Center for Oral Diseases, Center for Tissue Engin…
  • State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration & National Clinical Research Center for Oral Diseases & Shaanxi Clinical Research Center for Oral Diseases & Department of Orthodontics, Schoo…
  • Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an, Shaanxi, 710004, China.
  • State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration & National Clinical Research Center for Oral Diseases & Shaanxi Engineering Research Center for Dental Materials and Advanced Manufacture, Dep…
  • Department of Obstetrics and Gynecology, Affiliated Guangren Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an No.4 Hospital, Xi'an, Shaanxi, 710004, China.
  • The First Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China. zhelidoctor@163.com.

Förderung

  • National Natural Science Foundation of China
  • Project of State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration
  • the Young Science and Technology Rising Star Project of Shaanxi Province
  • the "Rapid Response" Research projects
  • the China Postdoctoral Science Foundation

Zitieren

APA

Zhang, Z. Q., Yuan, Y., Zhang, X. H., Liu, J. N., Cao, Y., Liu, L., Yang, L. F., Xiao, Y. H., Huang, S. S., Sui, B. D., Liang, J. F., Chen, J., Bao, L., Liu, J. Y., Li, Y. Y., Li, Z., Zheng, C. X., & Jin, F. (2025). Recipient Periodic Fasting Promotes Osteogenesis of Implanted Mesenchymal Stromal Cell Aggregates and Safeguards Diabetic Mandibular Bone Regeneration. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-025-10975-9

Vancouver

Zhang ZQ, Yuan Y, Zhang XH, Liu JN, Cao Y, Liu L, et al. Recipient Periodic Fasting Promotes Osteogenesis of Implanted Mesenchymal Stromal Cell Aggregates and Safeguards Diabetic Mandibular Bone Regeneration. Stem Cell Reviews and Reports. 2025. doi:10.1007/s12015-025-10975-9

BibTeX
@article{Zhang2025,
  author = {Zhang, Zi-Qi and Yuan, Yuan and Zhang, Xiao-Hui and Liu, Jia-Ning and Cao, Yuan and Liu, Lu and Yang, Lu-Fan and Xiao, Yi-Han and Huang, Shan-Shan and Sui, Bing-Dong and Liang, Jian-Fei and Chen, Ji and Bao, Lei and Liu, Jin-Yu and Li, Yuan-Yuan and Li, Zhe and Zheng, Chen-Xi and Jin, Fang},
  title = {Recipient Periodic Fasting Promotes Osteogenesis of Implanted Mesenchymal Stromal Cell Aggregates and Safeguards Diabetic Mandibular Bone Regeneration},
  journal = {Stem Cell Reviews and Reports},
  year = {2025},
  doi = {10.1007/s12015-025-10975-9}
}
Kostenlos starten →